Related Experiment Videos
Effect of aprotinin on growth of 3-methylcholanthrene-induced squamous cell-carcinoma in mice
Gan
|April 1, 1980
Abstract:
The effect of aprotinin (Trasylol), a broad-spectrum inhibitor of proteinase, was studied on the growth of murine squamous cell carcinoma induced by 3-methylcholanthrene. In this tumor system, the administration of aprotinin was therapeutically effective. Histologically, aprotinin-treated tumor showed a significant hyperkeratosis.
Insights
Aprotinin (Trasylol), a proteinase inhibitor, demonstrated therapeutic effectiveness against 3-methylcholanthrene-induced murine squamous cell carcinoma. Tumors treated with aprotinin exhibited significant hyperkeratosis, indicating a notable histological change.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Squamous cell carcinoma is a common skin cancer.
- Proteinases play a role in tumor growth and progression.
- Aprotinin is a known inhibitor of various proteinases.
Purpose of the Study:
- To investigate the therapeutic effect of aprotinin on chemically induced murine squamous cell carcinoma.
- To analyze the histological changes in tumors following aprotinin administration.
Main Methods:
- Murine squamous cell carcinoma was induced using 3-methylcholanthrene.
- Aprotinin (Trasylol) was administered to the tumor-bearing mice.
- Tumor growth and histological features were evaluated.
Main Results:
- Aprotinin administration showed therapeutic efficacy in this tumor model.
- Histological examination revealed significant hyperkeratosis in aprotinin-treated tumors.
- This suggests a specific mechanism of action beyond simple tumor growth inhibition.
Conclusions:
- Aprotinin is a potential therapeutic agent for squamous cell carcinoma.
- The observed hyperkeratosis indicates a distinct biological response to aprotinin.
- Further research is warranted to elucidate the precise mechanisms involved.